Plain-language summaries of our most recent peer-reviewed publications — written for patients, clinicians, and journalists.
Published 2026-10-08 · Tracker digest
45 candidate interventions with trial evidence, 10 druggable gene targets and 14 registered trials for Alzheimer's disease, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
25 candidate interventions with trial evidence, 14 druggable gene targets and 15 registered trials for Crohn's disease and ulcerative colitis, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
28 candidate interventions with trial evidence, 12 druggable gene targets and 15 registered trials for NAFLD / MASH (fatty liver disease), indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
57 candidate interventions with trial evidence, 10 druggable gene targets and 14 registered trials for chronic kidney disease, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
54 candidate interventions with trial evidence, 13 druggable gene targets and 14 registered trials for rheumatoid arthritis, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
47 candidate interventions with trial evidence, 9 druggable gene targets and 14 registered trials for migraine, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
51 candidate interventions with trial evidence, 10 druggable gene targets and 14 registered trials for multiple sclerosis, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
55 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for alopecia Areata, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
55 candidate interventions with trial evidence, 15 druggable gene targets and 14 registered trials for asthma, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
52 candidate interventions with trial evidence, 9 druggable gene targets and 14 registered trials for atrial Fibrillation, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
51 candidate interventions with trial evidence, 7 druggable gene targets and 14 registered trials for bipolar Disorder, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
56 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for breast Cancer, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
52 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for carpal Tunnel Syndrome, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
58 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for cervical Cancer, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
58 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for chronic Pancreatitis, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
58 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for colorectal Cancer, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
57 candidate interventions with trial evidence, 10 druggable gene targets and 15 registered trials for COPD, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
56 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for cystic Fibrosis, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
53 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for endometriosis, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
54 candidate interventions with trial evidence, 14 druggable gene targets and 14 registered trials for epilepsy, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
43 candidate interventions with trial evidence, 6 druggable gene targets and 14 registered trials for fibromyalgia, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
47 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for gastroparesis, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
46 candidate interventions with trial evidence, 8 druggable gene targets and 15 registered trials for GERD (Acid Reflux), indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
56 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for glaucoma, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
51 candidate interventions with trial evidence, 5 druggable gene targets and 14 registered trials for gout, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
52 candidate interventions with trial evidence, 9 druggable gene targets and 14 registered trials for heart Failure, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
55 candidate interventions with trial evidence, 15 druggable gene targets and 14 registered trials for hepatitis C, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
53 candidate interventions with trial evidence, 13 druggable gene targets and 15 registered trials for hypertension, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
38 candidate interventions with trial evidence, 8 druggable gene targets and 14 registered trials for hypothyroidism, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
39 candidate interventions with trial evidence, 9 druggable gene targets and 14 registered trials for low Back Pain, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
59 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for lung Cancer, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
52 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for lupus Nephritis, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
49 candidate interventions with trial evidence, 14 druggable gene targets and 14 registered trials for major Depressive Disorder, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
60 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for melanoma, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
56 candidate interventions with trial evidence, 8 druggable gene targets and 14 registered trials for obesity, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
50 candidate interventions with trial evidence, 6 druggable gene targets and 14 registered trials for opioid Use Disorder, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
55 candidate interventions with trial evidence, 10 druggable gene targets and 14 registered trials for osteoarthritis, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
57 candidate interventions with trial evidence, 8 druggable gene targets and 14 registered trials for osteoporosis, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
58 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for ovarian Cancer, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
55 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for prostate Cancer, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
52 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for psoriasis (Nail / Palmoplantar), indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
51 candidate interventions with trial evidence, 7 druggable gene targets and 14 registered trials for psoriatic Arthritis, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
51 candidate interventions with trial evidence, 8 druggable gene targets and 14 registered trials for schizophrenia, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
55 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for sepsis, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
58 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for sickle Cell Disease, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
45 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for tinnitus, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
52 candidate interventions with trial evidence, 9 druggable gene targets and 14 registered trials for type 1 Diabetes, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
56 candidate interventions with trial evidence, 12 druggable gene targets and 14 registered trials for type 2 Diabetes, indexed in plain language with every source linked.
Read the note →Published 2026-10-08 · Tracker digest
53 candidate interventions with trial evidence, 0 druggable gene targets and 14 registered trials for vitiligo, indexed in plain language with every source linked.
Read the note →Published 2026-03-10 · Environmental Toxicology
Endocrine-disrupting chemicals are found in air, water, food, and everyday products. This review maps how common pollutants interfere with thyroid, reproductive, and metabolic hormones — and how remediation is progressing.
Read the note →Published 2026-02-11 · Hormone and Metabolic Research
Many people with post-acute COVID-19 (and post-vaccination) syndrome show disrupted cellular energy production. This review examines lactate, carbon dioxide, and fat oxidation as therapeutic axes.
Read the note →Published 2026-02-10 · Future Journal of Pharmaceutical Sciences
Early predictions said mRNA vaccine components would clear quickly. This systematic review examines evidence that modified mRNA, spike protein, and lipid nanoparticles stay detectable long after vaccination.
Read the note →